Patients implanted with brain chips from Elon Musk’s Neuralink have begun to control robots’ arms with their thoughts, the company said.
“Participants in our clinical trials have extended digital computer control to physical devices such as assistive robotic arms,” Neuralink posted Dec. 2 on X. “Over time, we plan to expand the range of devices controllable via Neuralink.”
The startup raised $650 million in venture capital funding in June, following the successful implantation of a brain-computer interface in a patient at University of Miami Health System in April.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.